Pacira BioSciences (PCRX) Other Non Operating Income (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Other Non Operating Income of -$135000.0 for Q1 2026, down 103.07% year-over-year from $4.4 million in Q1 2025, and down 102.47% quarter-over-quarter from $5.5 million in Q4 2025.
Pacira BioSciences (PCRX) Other Non Operating Income (2010 - 2026) Analysis & Trends
Pacira BioSciences' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$135000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 103.07% year-over-year to -$135000.0; the TTM figure through Mar 2026 stood at -$5.5 million (down 237.02% YoY), while the FY2025 annual figure was -$983000.0, down 163.54% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$135000.0, down from $5.5 million in the prior quarter.
- The five-year high for Other Non Operating Income was $7.5 million in Q2 2024, with the low at -$16.9 million in Q1 2023.
- The 5-year median for Other Non Operating Income is -$159000.0 (2024), against an average of -$2.3 million.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income sank 22939.13% in 2022, then soared 2894.8% in 2024.
- Pacira BioSciences' Other Non Operating Income stood at $81000.0 in 2022, then sank by 432.1% to -$269000.0 in 2023, then sank by 2833.46% to -$7.9 million in 2024, then surged by 169.26% to $5.5 million in 2025, then sank by 102.47% to -$135000.0 in 2026.
- Business Quant data shows PCRX's Other Non Operating Income at -$135000.0 in Q1 2026, $5.5 million in Q4 2025, and -$110000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Pacira BioSciences | 947.48 Mn | 696.45 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34,000.00 |
| Mar 31, 2026 | -135,000.00 |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | -110,000.00 |
| Jun 30, 2025 | -10.74 Mn |
| Mar 31, 2025 | 4.40 Mn |
| Dec 31, 2024 | -7.89 Mn |
| Jun 30, 2024 | 7.52 Mn |
| Mar 31, 2024 | -159,000.00 |
| Jun 30, 2023 | -269,000.00 |
| Mar 31, 2023 | -16.90 Mn |
| Dec 31, 2022 | 81,000.00 |
| Sep 30, 2022 | -10.60 Mn |
| Jun 30, 2022 | -647,000.00 |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | -46,000.00 |
| Jun 30, 2021 | -2.40 Mn |
| Mar 31, 2021 | -157,000.00 |
| Dec 31, 2020 | -10.64 Mn |
| Sep 30, 2020 | 2.71 Mn |